Zhongxing Liao

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. pmc Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer
    Xiaodong Zhang
    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 72:278-87. 2008
  2. ncbi request reprint Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer
    Zhongxing Liao
    Deapartment of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Clin Lung Cancer 4:356-65. 2003
  3. pmc Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma
    Li Ru He
    Department of Radiation Oncology, Cancer Center, Sun Yat sun University, Guangzhou, China
    BMC Cancer 15:1095. 2015
  4. pmc HPV seropositivity joints with susceptibility loci identified in GWASs at apoptosis associated genes to increase the risk of Esophageal Squamous Cell Carcinoma (ESCC)
    Ju Yang
    Departments of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
    BMC Cancer 14:501. 2014
  5. pmc TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy
    Xianglin Yuan
    Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
    PLoS ONE 8:e65659. 2013
  6. ncbi request reprint Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small-cell lung cancer
    Zhongxing Liao
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 97, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 53:558-65. 2002
  7. ncbi request reprint COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer
    Zhongxing Liao
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Expert Rev Anticancer Ther 4:543-60. 2004
  8. ncbi request reprint Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation
    Zhongxing Liao
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 64:700-8. 2006
  9. pmc TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy
    Xiaoxiang Guan
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, USA
    BMC Cancer 11:447. 2011
  10. doi request reprint Status of particle therapy for lung cancer
    Zhongxing Liao
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Acta Oncol 50:745-56. 2011

Collaborators

Detail Information

Publications119 found, 100 shown here

  1. pmc Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer
    Xiaodong Zhang
    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 72:278-87. 2008
    ....
  2. ncbi request reprint Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer
    Zhongxing Liao
    Deapartment of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Clin Lung Cancer 4:356-65. 2003
    ....
  3. pmc Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma
    Li Ru He
    Department of Radiation Oncology, Cancer Center, Sun Yat sun University, Guangzhou, China
    BMC Cancer 15:1095. 2015
    ..The purpose of the study was to identify the chronic comorbidities and/or commonly-used medications that impact EC patient survival...
  4. pmc HPV seropositivity joints with susceptibility loci identified in GWASs at apoptosis associated genes to increase the risk of Esophageal Squamous Cell Carcinoma (ESCC)
    Ju Yang
    Departments of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
    BMC Cancer 14:501. 2014
    ..We previously showed that human papillomavirus (HPV) serostatus was not an independent risk factor for esophageal squamous cell carcinoma(ESCC) in nonsmokers and nondrinkers; however, HPV increased the risk in smokers...
  5. pmc TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy
    Xianglin Yuan
    Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
    PLoS ONE 8:e65659. 2013
    ....
  6. ncbi request reprint Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small-cell lung cancer
    Zhongxing Liao
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 97, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 53:558-65. 2002
    ..To evaluate the effect of q.d. or b.i.d. radiotherapy (RT) on the outcome of patients with locally advanced non-small-cell lung cancer...
  7. ncbi request reprint COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer
    Zhongxing Liao
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Expert Rev Anticancer Ther 4:543-60. 2004
    ..Current clinical protocols and preliminary findings will also be summarized...
  8. ncbi request reprint Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation
    Zhongxing Liao
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 64:700-8. 2006
    ..To test the hypothesis that TS3'UTR polymorphisms predict outcomes in 146 Caucasian patients with esophageal adenocarcinoma treated with preoperative 5-fluorouracil-based chemoradiation...
  9. pmc TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy
    Xiaoxiang Guan
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, USA
    BMC Cancer 11:447. 2011
    ..However, few reported studies have investigated the association between potentially functional SNPs in both TNF-α and TNFRSF1B and prognosis of NSCLC patients treated with chemoradiotherapy...
  10. doi request reprint Status of particle therapy for lung cancer
    Zhongxing Liao
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Acta Oncol 50:745-56. 2011
    ....
  11. ncbi request reprint A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer
    Zhongxing Liao
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Clin Cancer Res 11:3342-8. 2005
    ....
  12. ncbi request reprint Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?
    Zhongxing Liao
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Drugs 67:821-45. 2007
    ..This review discusses the role of COX-2, its products (prostaglandins) and its inhibitors in tumour growth and treatment...
  13. ncbi request reprint Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer
    Zhongxing Liao
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Am J Clin Oncol 26:S85-91. 2003
    ..The rationale for using selective COX-2 inhibitors is discussed, and the current clinical protocols and the initial findings are described...
  14. doi request reprint Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus
    Heta Javeri
    Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 113:1302-8. 2008
    ..Whether the type of therapy influences the outcomes remains largely unanswered. It is hypothesized that induction chemotherapy (IC) or the type of cytotoxics used would not influence patient outcomes...
  15. ncbi request reprint Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients
    Zhongxing Liao
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 60:1484-93. 2004
    ..To evaluate the effect of surgical resection on the outcome of patients with clinical Stage II or III cancer of the esophagus treated with concurrent chemoradiotherapy...
  16. pmc Predictors of postoperative complications after trimodality therapy for esophageal cancer
    Jingya Wang
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Int J Radiat Oncol Biol Phys 86:885-91. 2013
    ..The goal of this study was to identify modifiable factors associated with postoperative complications after neoadjuvant chemoradiation...
  17. ncbi request reprint Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy
    Ritsuko Komaki
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX 77030, USA
    Semin Oncol 32:S92-8. 2005
    ..AMF reduced the incidence of grade 3/4 lung fibrosis among higher MS. These data suggest that MS might help identify subgroups of patients who could receive more benefit from AMF with respect to lung damage...
  18. ncbi request reprint Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery
    Susan L Tucker
    Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 66:754-61. 2006
    ..The aim of this study was to investigate the effect of radiation dose distribution in the lung on the risk of postoperative pulmonary complications among esophageal cancer patients...
  19. doi request reprint Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer
    Samir Sejpal
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Cancer 117:3004-13. 2011
    ..We hypothesized that proton beam therapy for most patients with NSCLC could permit higher tumor doses with less normal-tissue toxicity than photon RT delivered as 3-dimensional conformal RT (3D-CRT) or intensity-modulated RT (IMRT)...
  20. ncbi request reprint Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagus
    Pooja R Rohatgi
    Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA
    Int J Gastrointest Cancer 36:69-76. 2005
    ..To analyze the differences in clinical stage, pathologic response to chemoradiotherapy, patterns of failure, and overall survival (OS) between patients with squamous cell carcinoma (SCC) and adenocarcinoma (ACA) of the esophagus...
  21. ncbi request reprint The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation
    Yan Gu
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 106:1017-25. 2006
    ..However, the prognostic significance of the number of LNs with residual metastasis remains unclear...
  22. ncbi request reprint Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus
    Pooja R Rohatgi
    Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 104:1349-55. 2005
    ..The current study was conducted to test the hypothesis that patterns of failure are correlated with the degree of residual carcinoma after preoperative chemoradiotherapy (CRT) in patients with esophageal carcinoma...
  23. doi request reprint Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer
    Qingsong Pang
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 97, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 85:1332-9. 2013
    ..We investigated potential associations between single nucleotide polymorphisms (SNPs) in HSPB1 and risk of RP after chemoradiation for non-small cell lung cancer (NSCLC)...
  24. pmc Esophageal cancer dose escalation using a simultaneous integrated boost technique
    James Welsh
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 82:468-74. 2012
    ..We performed a planning study to evaluate if a simultaneous integrated boost (SIB) technique could selectively deliver a boost dose of radiation to the GTV in patients with esophageal cancer...
  25. doi request reprint The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma
    Santosh B Murthy
    Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Oncology 78:316-22. 2010
    ..We hypothesized that the standardized uptake value (SUV) of positron emission tomography (PET) after chemoradiation would define the clinical outcome in patients...
  26. ncbi request reprint Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer
    Ramesh Gopal
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 56:114-20. 2003
    ..To evaluate the effects of chemoradiation on objective tests of pulmonary function...
  27. ncbi request reprint Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters
    Hoon K Lee
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 57:1317-22. 2003
    ..To clarify the relationship between the percentage of lung receiving low radiation doses with concurrent chemotherapy and the occurrence of postoperative pulmonary complications in the treatment of esophageal carcinoma...
  28. doi request reprint Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer
    Jose Luis Lopez Guerra
    The University of Texas, Houston, TX 77054, USA
    Radiother Oncol 105:299-304. 2012
    ....
  29. pmc Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer
    Daniel R Gomez
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA
    Int J Radiat Oncol Biol Phys 86:665-70. 2013
    ..Hypofractionated radiation regimens, if tolerable, may provide an option to these patients for effective local control...
  30. doi request reprint Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma
    Daniel R Gomez
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77054, USA
    J Thorac Oncol 8:238-45. 2013
    ....
  31. pmc Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy
    Xiaoxiang Guan
    Department of Epidemiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, USA
    BMC Cancer 10:431. 2010
    ..We hypothesized that VEGF polymorphisms may affect survival outcomes among locally advanced non-small cell lung cancer (LA-NSCLC) patients...
  32. doi request reprint Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer
    Susan L Tucker
    Department of Bioinformatics and Computational Biology, University of Texas M D Anderson Cancer Center, Houston, Texas 77230 1402, USA
    Int J Radiat Oncol Biol Phys 77:691-8. 2010
    ....
  33. ncbi request reprint Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma
    David C Rice
    Department of Thoracic and Cardiovascular Surgery, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Thorac Surg 84:1685-92; discussion 1692-3. 2007
    ..To improve local control, we have used intensity-modulated radiation therapy (IMRT) as it allows better dose distribution to regions at risk of recurrence as well as reduced radiation to surrounding organs...
  34. ncbi request reprint Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy
    Xiong Wei
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 66:100-7. 2006
    ..To determine the risk factors for acute esophagitis (AE) in non-small-cell lung cancer (NSCLC) patients treated with concurrent chemotherapy (CCT) and three-dimensional conformal radiotherapy (3D-CRT)...
  35. ncbi request reprint Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial
    Ritsuko Komaki
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 58:1369-77. 2004
    ..To determine the ability of amifostine to reduce the severity and/or incidence of the acute toxicities of concurrent chemotherapy and radiotherapy (RT) for non-small-cell lung cancer...
  36. pmc Patient-specific quantification of respiratory motion-induced dose uncertainty for step-and-shoot IMRT of lung cancer
    Heng Li
    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030
    Med Phys 40:121712. 2013
    ..The objective of this study was to quantify respiratory motion-induced dose uncertainty at the planning stage for step-and-shoot intensity-modulated radiation therapy (IMRT) using an analytical technique...
  37. pmc Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy
    Ming Yin
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 81:e67-73. 2011
    ....
  38. ncbi request reprint Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy
    Sue S Yom
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 68:94-102. 2007
    ..To investigate the rate of high-grade treatment-related pneumonitis (TRP) in patients with advanced non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and intensity-modulated radiotherapy (IMRT)...
  39. ncbi request reprint Target definition and contouring in carcinoma of the lung and esophagus
    Ritsuko Komaki
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Rays 28:225-36. 2003
    ..There we review the normal anatomy, diagnostic methods, and tumor delineation of cancer of the lung and esophagus...
  40. pmc Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis
    Susan L Tucker
    Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230 1402, USA
    Int J Radiat Oncol Biol Phys 85:251-7. 2013
    ....
  41. pmc Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer
    José Luis López Guerra
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 83:1573-9. 2012
    ..Here we investigated whether the extent of change in diffusing capacity of the lung for carbon monoxide (DLCO) after radiation therapy (RT) for non-small-cell lung cancer (NSCLC) could be used as an objective means of quantifying RP...
  42. pmc Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy
    Xin Shelley Wang
    Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Brain Behav Immun 26:699-705. 2012
    ..0001). This longitudinal study suggests a role for over-expressed sTNF-R1 and IL-6 in the development of fatigue and other severe sickness symptoms during CXRT in patients with colorectal or esophageal cancer...
  43. pmc Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era
    Arya Amini
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Radiat Oncol Biol Phys 83:e231-9. 2012
    ....
  44. pmc Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study
    James Welsh
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 81:1336-42. 2011
    ..In the present study, we compared the dosimetric parameters for photon IMRT with that for intensity-modulated proton therapy (IMPT) for unresectable, locally advanced, distal esophageal cancer...
  45. pmc Analysis of radiation pneumonitis risk using a generalized Lyman model
    Susan L Tucker
    Department of Bioinformatics and Computational Biology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Radiat Oncol Biol Phys 72:568-74. 2008
    ....
  46. ncbi request reprint Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma
    Julie G Izzo
    Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
    Mol Cancer Ther 5:2844-50. 2006
    ..We hypothesized that activated NF-kappaB would define clinical biology irrespective of the type of chemotherapy or sequence administered...
  47. ncbi request reprint Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone
    Eugene H Huang
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 68:779-85. 2007
    ..To retrospectively compare outcomes for patients with unresectable locally advanced non-small-cell lung cancer (NSCLC) treated at our institution with concurrent chemoradiation with or without induction chemotherapy...
  48. pmc Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer
    Joe Y Chang
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 72:967-71. 2008
    ..To evaluate the efficacy and adverse effects of image-guided stereotactic body radiation therapy (SBRT) in centrally/superiorly located non-small-cell lung cancer (NSCLC)...
  49. ncbi request reprint Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer
    Hasan Murshed
    Division of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 58:1258-67. 2004
    ....
  50. ncbi request reprint Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response
    Pooja Rohatgi
    Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 104:2365-72. 2005
    ....
  51. ncbi request reprint Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy
    Pooja R Rohatgi
    Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 106:552-8. 2006
    ..The current study tested the hypothesis that the clinical outcome of patients with localized esophageal carcinoma after preoperative chemoradiotherapy (CTRT) depends on histology...
  52. ncbi request reprint Radiation pneumonitis: local dose versus [18F]-fluorodeoxyglucose uptake response in irradiated lung
    Thomas Guerrero
    Division of Radiation Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 68:1030-5. 2007
    ..To quantify the relationship between the local radiation dose received and the posttreatment positron emission tomography/computed tomography (PET/CT) [(18)F]2-fluoro-2-deoxyglucose (FDG) uptake in the lung...
  53. ncbi request reprint Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma
    David C Rice
    Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 69:350-7. 2007
    ..To determine the incidence of fatal pulmonary events after extrapleural pneumonectomy and hemithoracic intensity-modulated radiotherapy (IMRT) for malignant pleural mesothelioma...
  54. ncbi request reprint Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: Part II-margin reduction of internal target volume
    H Helen Liu
    Division of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 60:1473-83. 2004
    ....
  55. pmc Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy
    Juyi Wen
    Department of Radiation Oncology, Navy General Hospital, Beijing, China Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Eur J Cancer 50:1706-16. 2014
    ..However, no published study has investigated associations between genetic variants in LIN28 and radiation-induced pneumonitis (RP) in patients with non-small cell lung cancer (NSCLC) treated with definitive radiation therapy...
  56. ncbi request reprint Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma
    S Chris Malaisrie
    Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, Tex 77030, USA
    J Thorac Cardiovasc Surg 131:65-72. 2006
    ..We reviewed our experience with preoperative chemoradiotherapy in patients with adenocarcinoma of the distal esophagus and pretreatment endoscopic ultrasonography-identified celiac adenopathy...
  57. ncbi request reprint Attenuation correction of PET cardiac data with low-dose average CT in PET/CT
    Tinsu Pan
    Department of Imaging Physics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Med Phys 33:3931-8. 2006
    ..In conclusion, low-dose ACT improved registration of the CT and the PET data in the heart region in our study of four patients. ACT was superior than SSCT for depicting average respiration motion in a patient study...
  58. pmc Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
    Joe Y Chang
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, USA
    Radiat Oncol 7:152. 2012
    ..However, factors that may predict toxicity or survival are largely unknown. We sought here to identify predictors of survival and pneumonitis after SABR for NSCLC in a relatively large single-institution series...
  59. pmc Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer
    Steven H Lin
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Int J Radiat Oncol Biol Phys 84:1078-85. 2012
    ..We hypothesized that the dosimetric advantages of IMRT should translate to substantive benefits in clinical outcomes compared with 3D-CRT...
  60. pmc Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis
    José Luis López Guerra
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Int J Radiat Oncol Biol Phys 84:e61-7. 2012
    ..We investigated prognostic factors associated with survival in patients with non-small cell lung cancer (NSCLC) and oligometastatic disease at diagnosis, particularly the influence of local treatment to the primary site on prognosis...
  61. pmc Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer
    Jose L Lopez Guerra
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Int J Radiat Oncol Biol Phys 83:e537-43. 2012
    ....
  62. doi request reprint Image-guided radiation therapy for non-small cell lung cancer
    Joe Y Chang
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Thorac Oncol 3:177-86. 2008
    ....
  63. doi request reprint Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer
    Ralph G Zinner
    Department of Thoracic Head and Neck Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 73:119-27. 2009
    ....
  64. pmc Effects of respiration-averaged computed tomography on positron emission tomography/computed tomography quantification and its potential impact on gross tumor volume delineation
    Pai Chun Melinda Chi
    Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 71:890-9. 2008
    ..In this study, respiration-averaged CT (ACT) was used to remove the artifacts, and the changes in standardized uptake value (SUV) and gross tumor volume (GTV) were quantified...
  65. ncbi request reprint Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer
    H Helen Liu
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 58:1268-79. 2004
    ....
  66. ncbi request reprint High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy
    Joe Y Chang
    Department of Radiation Oncology, Epidemiology, and Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 11:2894-8. 2005
    ....
  67. doi request reprint Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy
    Xiong Wei
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 70:707-14. 2008
    ..To identify clinical and dosimetric factors influencing the risk of pericardial effusion (PCE) in patients with inoperable esophageal cancer treated with definitive concurrent chemotherapy and radiation therapy (RT)...
  68. doi request reprint Patterns of cardiac perfusion abnormalities after chemoradiotherapy in patients with lung cancer
    Isis W Gayed
    Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Thorac Oncol 4:179-84. 2009
    ..We evaluated the prevalence of myocardial perfusion defects using myocardial perfusion imaging (MPI) after chemoradiation or radiation therapy (CRT/RT) in lung cancer patients and described their patterns in relation to tumor location...
  69. doi request reprint Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort
    Grace L Smith
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Int J Radiat Oncol Biol Phys 74:482-9. 2009
    ..Optimal management of elderly patients with nonmetastatic esophageal cancer is unclear. Outcomes data after locoregional treatment are lacking for this group...
  70. doi request reprint Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography
    Srikrishna V Patnana
    Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 116:4487-94. 2010
    ..High SUV (HSUV) after chemoradiation portends a poor prognosis. The authors retrospectively examined the role of surgery in patients with HSUV after chemoradiation...
  71. ncbi request reprint Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest
    Anesa Ahamad
    Department of Radiation Oncology, Section of Thoracic Molecular Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer J 9:476-84. 2003
    ..We report how these geometric/dosimetric constraints were overcome by exploiting intensity-modulated radiotherapy in the first cohort patient...
  72. ncbi request reprint The relationship between local dose and loss of function for irradiated lung
    Ramesh Gopal
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 56:106-13. 2003
    ..To determine the relationship between the local radiation dose and the decrease in lung function associated with thoracic irradiation...
  73. ncbi request reprint Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response
    Jennifer Sims-Mourtada
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 12:6565-72. 2006
    ..However, the relationship between Hh signaling and therapeutic response is unknown...
  74. pmc Proton beam therapy and concurrent chemotherapy for esophageal cancer
    Steven H Lin
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 83:e345-51. 2012
    ..We report our preliminary experience of treating esophageal cancer patients with concurrent chemotherapy (CChT) and PBT (CChT/PBT) at MD Anderson Cancer Center...
  75. pmc Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy
    Xin Shelley Wang
    Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Brain Behav Immun 24:968-74. 2010
    ....
  76. ncbi request reprint Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma
    Julie G Izzo
    Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Clin Oncol 24:748-54. 2006
    ..Nuclear factor kappaB (NF-kappaB), a transcriptional factor, is constitutively activated or treatment induced in esophageal cancer and may influence treatment outcomes...
  77. doi request reprint The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma
    Heta Javeri
    Department of Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 115:5184-92. 2009
    ..Analyses of dichotomized data are commonly reported. The authors analyzed percentage SUV decrease as both dichotomized and continuous variables...
  78. ncbi request reprint Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography
    Brian P Yaremko
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 70:145-53. 2008
    ..To investigate the motion characteristics of distal esophagus cancer primary tumors using four-dimensional computed tomography (4D CT)...
  79. ncbi request reprint 4D Proton treatment planning strategy for mobile lung tumors
    Yixiu Kang
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Int J Radiat Oncol Biol Phys 67:906-14. 2007
    ..To investigate strategies for designing compensator-based 3D proton treatment plans for mobile lung tumors using four-dimensional computed tomography (4DCT) images...
  80. ncbi request reprint Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma
    David Hong
    Department of GI Medical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 104:1620-6. 2005
    ..The authors tested the hypothesis that, in this setting, the number of PET abnormalities (NPA) would correlate with OS and DFS...
  81. ncbi request reprint Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging
    Jeremy J Erasmus
    Department of Diagnostic Imaging, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Thorac Oncol 1:478-86. 2006
    ..We evaluated the use of integrated computed tomography (CT)-PET among patients with esophageal cancer being considered for resection after CRT...
  82. pmc Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer
    Shu Lian Wang
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX 77030, USA
    World J Gastroenterol 12:5501-8. 2006
    ..To evaluate the dosimetry, efficacy and toxicity of intensity-modulated radiation therapy (IMRT) and concurrent chemotherapy for patients with locally advanced cervical and upper thoracic esophageal cancer...
  83. ncbi request reprint Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection
    Banke Agarwal
    Department of GI Medicine and Nutrition, Medical Oncology and Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, Houston, Texas, USA
    Am J Gastroenterol 99:1258-66. 2004
    ..Based on these data, we reevaluated the role of EUS in identifying patients who maximally benefit from surgical esophageal resection after preoperative chemoXRT...
  84. doi request reprint Daily alignment results of in-room computed tomography-guided stereotactic body radiation therapy for lung cancer
    Hitoshi Ikushima
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 79:473-80. 2011
    ....
  85. ncbi request reprint Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors
    Eiko Nakata
    Department of Experimental Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
    Int J Radiat Oncol Biol Phys 58:369-75. 2004
    ..The results show that selective COX-2 inhibitors have the potential to improve tumor radiotherapy or radiochemotherapy, and this therapeutic strategy is currently under clinical testing...
  86. pmc Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation
    Patrick Kelly
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 78:1387-93. 2010
    ..In this study, we retrospectively reviewed outcomes after SBRT for recurrent disease among patients previously given radiation therapy to the chest...
  87. ncbi request reprint Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer
    Yoshiyuki Shioyama
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 68:1349-58. 2007
    ..To assess quantitatively the impact of incorporating functional lung imaging into intensity-modulated radiation therapy planning for locally advanced non-small cell lung cancer (NSCLC)...
  88. doi request reprint Impact of using different four-dimensional computed tomography data sets to design proton treatment plans for distal esophageal cancer
    Xiaoning Pan
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 73:601-9. 2009
    ..To study the impact of selecting different data sets from four-dimensional computed tomography (4D CT) imaging during proton treatment planning in patients with distal esophageal cancer...
  89. ncbi request reprint Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma
    Anesa Ahamad
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 55:768-75. 2003
    ..Intensity-modulated radiation therapy (IMRT) has the potential to overcome these geometric/dosimetric constraints...
  90. ncbi request reprint Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer
    Ritsuko Komaki
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Semin Oncol 31:47-53. 2004
    ..Here we discuss the rationale for using selective COX-2 inhibitors and describe current clinical protocols and the initial findings...
  91. pmc Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer
    Michelle A T Hildebrandt
    Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
    PLoS ONE 5:e12402. 2010
    ..These results suggest that genetic variations among inflammation pathway genes may modulate the development of radiation-induced toxicity and, ultimately, help in identifying patients who are at an increased likelihood for such events...
  92. ncbi request reprint Dosimetric benefits of respiratory gating: a preliminary study
    Laura E Butler
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Appl Clin Med Phys 5:16-24. 2004
    ..Respiratory gating of thoracic radiation treatments can often improve the quality of the treatment plan, but it may not be possible to determine which patients may benefit from gating prior to performing the actual treatment planning...
  93. doi request reprint The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy
    Isis Gayed
    Department of Nuclear Medicine, University of Texas M D Anderson Cancer Center, 6431 Fannin Street, Houston, TX 77030, USA
    Int J Cardiovasc Imaging 25:487-95. 2009
    ..This study aims to identify the clinical implications of myocardial perfusion defects after chemoradiation therapy (CRT) in patients with esophageal and lung cancer...
  94. ncbi request reprint The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer
    Isis W Gayed
    Department of Nuclear Medicine, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    J Nucl Med 47:1756-62. 2006
    ..However, the prevalence and association of such abnormalities with RT in esophageal cancer patients have not been investigated previously...
  95. doi request reprint Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications
    Alexander Chi
    Department of Radiation Oncology, University of Arizona, 1501 N Campbell Ave, Tucson, AZ 85724, USA
    Radiother Oncol 94:1-11. 2010
    ..To analyze the patterns of failure, the toxicity profile, and the factors influencing efficacy of stereotactic body radiation (SBRT) for early-stage non-small-cell lung cancer (NSCLC)...
  96. ncbi request reprint Heterogeneous planning for homogeneous protocols
    Chris Brooks
    Radiation Physics, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    Med Dosim 29:80-4. 2004
    ..This paper describes a procedure that has been developed to satisfy the requirements of a homogeneous protocol, such as RTOG 98-01 (A Phase III Study of Amifostine mucosal protection), while maintaining accuracy in treatment planning...
  97. ncbi request reprint Huachansu, containing cardiac glycosides, enhances radiosensitivity of human lung cancer cells
    Li Wang
    Department of Experimental Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Anticancer Res 31:2141-8. 2011
    ..To assess radiosensitzing potential of huachansu (HCS) and delineate the underlying mechanisms...
  98. ncbi request reprint Radiochemotherapy of esophageal cancer
    Zhongxing Liao
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer, Houston, Texas 77030, USA
    J Thorac Oncol 2:553-68. 2007
    ..Innovative treatment strategies including physically and biologically molecular targeted therapy is needed to improve the treatment outcome of patients with esophageal cancer...
  99. doi request reprint Improved long-term outcome with chemoradiotherapy strategies in esophageal cancer
    Stephen G Swisher
    Department of Thoracic and Cardiovascular Surgery, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Thorac Surg 90:892-8; discussion 898-9. 2010
    ..We therefore reviewed sequential phase II/III trials performed at a single institution to assess the impact of preoperative chemotherapy versus preoperative C/RT strategies...
  100. ncbi request reprint Treatment planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription
    Steven J Frank
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 56:1308-18. 2003
    ..To quantify the differences in doses to target volumes and critical thoracic structures calculated by traditional homogeneous point-dose prescription and heterogeneity-corrected volume-dose prescription...
  101. pmc Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113
    Jaffer A Ajani
    Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Clin Oncol 26:4551-6. 2008
    ..The primary end point was to assess whether any approach would achieve a >or= 77.5% 1-year survival rate, surpassing the historical 66% rate from the Radiation Therapy Oncology Group (RTOG) protocol 9405...